My baby raccoons they pushed over my garbage and got the rest of the cake. I guess it's my fault. I ordered a large Strawberry & Cream cake for the 4th. And it was basically just me eating it. So I gave some two nights to the babies and Hamilton. They loved it! I gave them a bowl of water for them to clean their perfect fingers and toes... and this is how they repay me- a pushed over garbage raid... Ok... lets see how they feel when I'm gone now for a week..
Idea #1-->Flowserve Corporation- I kind of blew this the other day @ target entry:$52.25<---- Lets just say $52.75. This is the price I want./ $55.291.30(+2.41%)1:00 PM 07/03/25 NYSE |$USD |Pre-Market:$55.00-0.29(-0.52%)8:14 AM
Idea#2-->Beam Therapeutics Inc. $20 happens to be mild resistance. Over $20.25 = move to $25-$30. Watch!! $20.01 0.13(+0.65%)1:00 PM 07/03/25 NASDAQ |$USD |Pre-Market:$19.93-0.08(-0.40%)8:52 AM
Idea #3-->Parsons Corporation $74.81 0.90(+1.22%)1:00 PM 07/03/25 NYSE |$USD |Pre-Market:$74.80-0.01(-0.01%)8:38 AM Want to look into this purchase: Parsons buys Chesapeake Technologies International for $89 million NewsTue, Jul. 01 $68 is very good support<---- So my goal is this month as we head to Aug to be aware of that $68 level.
SN SharkNinja, Inc.- This one just missed the GBA list/// I like it better at $98-$99 On watch. $107.24 0.88(+0.83%)1:00 PM 07/03/25 NYSE |$USD |Pre-Market:$106.19-1.05(-0.98%)8:37 AM
$31------>$46 DRS +2.43% What a fantastic six months it’s been for Leonardo DRS. Shares of the company have skyrocketed 44.9%, setting a new 52-week high of $46.91. This was partly due to its solid quarterly results, and the performance may have investors wondering how to approach the situation. Why Does Leonardo DRS Spark Debate? Developing submarine detection systems for the U.S. Navy, Leonardo DRS (NASDAQRS) is a provider of defense systems, electronics, and military support services. Two Things to Like: 1. Surging Backlog Locks In Future Sales In addition to reported revenue, backlog is a useful data point for analyzing Defense Contractors companies. This metric shows the value of outstanding orders that have not yet been executed or delivered, giving visibility into Leonardo DRS’s future revenue streams. Leonardo DRS’s backlog punched in at $8.61 billion in the latest quarter, and over the last two years, its year-on-year growth averaged 54.4%. This performance was fantastic and shows the company has a robust sales pipeline because it is accumulating more orders than it can fulfill. Its growth also suggests that customers are committing to Leonardo DRS for the long term, enhancing the business’s predictability. Leonardo DRS Backlog 2. Outstanding Long-Term EPS Growth Analyzing the change in earnings per share (EPS) shows whether a company's incremental sales were profitable – for example, revenue could be inflated through excessive spending on advertising and promotions. Leonardo DRS’s full-year EPS grew at an astounding 17.5% compounded annual growth rate over the last two years, better than the broader industrials sector. Leonardo DRS Trailing 12-Month EPS (Non-GAAP) One Reason to be Careful: New Investments Fail to Bear Fruit as ROIC Declines ROIC, or return on invested capital, is a metric showing how much operating profit a company generates relative to the money it has raised (debt and equity). We like to invest in businesses with high returns, but the trend in a company’s ROIC is what often surprises the market and moves the stock price. Over the last few years, Leonardo DRS’s ROIC has unfortunately decreased. Only time will tell if its new bets can bear fruit and potentially reverse the trend. Leonardo DRS Trailing 12-Month Return On Invested Capital Final Judgment Leonardo DRS’s merits more than compensate for its flaws, and with the recent rally, the stock trades at 42.7× forward P/E (or $46.91 per share) Hummmmmmmmmmmmmmmmmmmmmmm
HELP-! HELP WHAT IS GOING ON!!! COGTCogent Biosciences, Inc. $9.71 +2.13(+28.10%)10:55 AM 07/07/25 NASDAQ |$USD |Realtime WHATS THE STORY... I'M CLEANING////// TO SELL THIS I HAVE TO MAYBE GET A CODE. LET ME CHECK. What the hell is going on????? Cogent Biosciences price target raised by $2 at Leerink, here's why » 10:47 COGT
We Did it!///////////////////// Quantity Symbol Price type Term Price Price executed Status Links 07/07/25 1047 Stock/ETF Sell 1,500 COGT Limit Day 9.61 9.6401 Executed
I don't think this is my replacement.. but interesting angle here. Apparently the Republican side the wacky stuff... The raspy voiced guy.... apparently everyone is very supportive of psychedelics. ATAI Atai Life Sciences N.V. $2.19---$2.73... Hummmmmm $2.73-0.04(-1.44%)11:05 AM 07/07/25 NASDAQ |$USD |Realtime